IL6 and diabetes mellitus: In previous studies, cataract surgery may induce the elevation of vascular endothelial growth factor, monocyte chemotactic protein-1, interleukin-1β (IL-1β), and IL-6 in the aqueous fluid of patients with and without diabetes by causing changes to the blood–retinal barrier [41, 42].